share_log

Natural Health Trends Corp. (NHTC) Q3 2024 Earnings Call Transcript Summary

Natural Health Trends Corp. (NHTC) Q3 2024 Earnings Call Transcript Summary

Natural Health Trends Corp.(NHTC)2024年第三季度業績會議通話摘要
富途資訊 ·  10/31 03:10  · 電話會議

The following is a summary of the Natural Health Trends Corp. (NHTC) Q3 2024 Earnings Call Transcript:

以下是自然健康趨勢公司(NHTC)2024年第三季度業績會的簡報:

Financial Performance:

金融業績:

  • Q3 2024 revenue was $10.7 million, marking a 1% increase year-over-year.

  • Gross profit margin declined to 74.1% from 74.7% due to higher costs associated with Premium Noni Juice.

  • Operating loss improved sequentially over three quarters, recording $275,000 this quarter.

  • Net income amounted to $35,000, or breakeven per diluted share.

  • 2024年第三季度營業收入爲1070萬美元,同比增長1%。

  • 毛利潤率由74.7%下降至74.1%,主要是由於優質諾尼果汁帶來了更高的成本。

  • 營業虧損在三個季度內逐步改善,本季度記錄爲275,000美元。

  • 淨利潤爲35,000美元,每股攤薄盈利爲持平。

Business Progress:

業務進展:

  • Expanded into the Colombian market, officially opening on October 1.

  • Announced the introduction of new products such as Skindulgence revitalizing serum, eye cream, and other health supplements.

  • Continues to invest in digital enhancements expected to enhance member productivity and sales experience, set to launch early next year.

  • 正式進軍哥倫比亞市場,並於10月1日正式開業。

  • 宣佈推出新產品,如Skindulgence活膚精華、眼霜和其他保健補充品。

  • 繼續投資於數字增強功能,預計將提高會員生產力和銷售體驗,計劃明年初推出。

Opportunities:

機會:

  • Market expansion through opening in Colombia and broad potential across Latin America.

  • Product innovation with new health supplements and personal care products.

  • Continued investment in digital tools to improve the selling and shopping experience.

  • 通過在哥倫比亞開拓市場擴張,在拉丁美洲廣泛潛力。

  • 通過推出新的健康補充品和個護用品進行產品創新。

  • 持續投資於數字工具,以改善銷售和購物體驗。

Risks:

風險:

  • Active member base decreased by 11% year-over-year, which may impact future revenue and sales.

  • 活躍會員基數同比減少11%,可能影響未來的營收和銷售。

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.

提示:如需更全面的詳情,請參閱投資人關係網站。本文僅供投資者參考,不作任何指引或建議。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論